Technology | 2019.10.08
ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
Antibodies show highly selective binding to pathogenic forms of alpha-synuclein implicated in multiple system atrophy TORONTO and CAMBRIDGE, MA, Oct. 8, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-system-atrophy-300933407.html
